Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death

FDA review determines that long-term use of clopidogrel does not increase/decrease overall risk of death in patients with, or at risk for, heart disease, and does not suggest that clopidogrel increases risk of cancer/death from cancer.

 
comments powered by Disqus